津药药业(600488.SH)：上半年净利润4930.42万元，同比下降65.28%

Group 1 - The core viewpoint of the article is that Tianyao Pharmaceutical (600488.SH) reported a decline in both revenue and net profit for the first half of 2025 [1] Group 2 - The company achieved an operating income of 1.588 billion yuan, representing a year-on-year decrease of 11.81% [1] - The net profit attributable to shareholders of the listed company was 49.3042 million yuan, down 65.28% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 117 million yuan, a year-on-year decrease of 16.47% [1] - The basic earnings per share were 0.045 yuan [1]